Valuing ResApp Health, page-248

Thought about how the conflict of T/O is caused from below reality

*BOD - Very tired, running out of their wits to commercialize RAP, desperately want to sell out, they need everyone validate their past achievements

*Investors - Very confused, concerned about company potential and our investment more than handling to anybody else at cheap price

Problem: Company Policy makers are not supported by majority of investors while chance and risk are both huge at present

Possible solutions:
1 Sell out at a price most investors can accept, this will require BOD work harder for a much higher offer, the reward is they can offload happily
2 BOD partially shuffled to get momentum back for better commercialization, this will somehow discourage team as they have worked many years within their scope of knowledge
3 BOD completely changed so better policy can be made to represent investors interest, but they will fight back as this is not validating their past work


It is likely current BOD will keep running RAP if Pfizer walk away from the offer failure, which is not a good result at all. The conflict gap has been at its greatest since Covid test results published. Guys, time for a change, we just have to give them a big thank you and welcome someone more passionate and professional to step up RAP for us. All IMO